Symbols / ANIP Stock $82.72 -0.06% ANI Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
ANIP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Nikhil Lalwani
Exch · Country NGM · United States
Market Cap 1.88B
Enterprise Value 2.06B
Income 83.94M
Sales 923.71M
FCF (ttm) 140.26M
Book/sh 26.34
Cash/sh 15.38
Employees 970
Insider 10d —
IPO May 05, 2000
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 21.16
Forward P/E 7.80
PEG —
P/S 2.04
P/B 3.14
P/C —
EV/EBITDA 10.43
EV/Sales 2.23
Quick Ratio 2.43
Current Ratio 3.12
Debt/Eq 112.08
LT Debt/Eq —
EPS (ttm) 3.91
EPS next Y 10.61
EPS Growth 86.10%
Revenue Growth 20.50%
EPS Gr Q/Q 88.10%
Rev Gr Q/Q —
Earnings (next) 2026-08-07
Earnings (prior) 2026-05-08
ROA 4.97%
ROE 18.32%
ROIC —
Gross Margin 60.83%
Oper. Margin 16.30%
Profit Margin 9.98%
Shs Outstand 22.73M
Shs Float 19.46M
Insider Own 6.89%
Instit Own 110.24%
Short Float 18.98%
Short Ratio 10.78
Short Interest 3.56M
52W High 99.50
vs 52W High -16.86%
52W Low 57.33
vs 52W Low 44.29%
Beta 0.46
Impl. Vol. 62.79%
Rel Volume 1.44
Avg Volume 371.66K
Volume 536.32K
Target (mean) $109.88
Tgt Median $110.00
Tgt Low $90.00
Tgt High $124.00
# Analysts 8
Recom Buy
Prev Close $82.77
Price $82.72
Change -0.06%
About

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$109.88
Mean price target
2. Current target
$82.72
Latest analyst target
3. DCF / Fair value
$111.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$82.72
Low
$90.00
High
$124.00
Mean
$109.88

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-16 main Guggenheim Buy → Buy $124
2025-12-09 init Barclays — → Overweight $100
2025-11-10 main Guggenheim Buy → Buy $115
2025-10-09 main Truist Securities Hold → Hold $90
2025-09-24 main JP Morgan Overweight → Overweight $115
2025-09-17 main HC Wainwright & Co. Buy → Buy $121
2025-09-08 main Guggenheim Buy → Buy $114
2025-08-11 main Truist Securities Hold → Hold $77
2025-08-08 main HC Wainwright & Co. Buy → Buy $93
2025-07-10 init HC Wainwright & Co. — → Buy $84
2025-05-12 reit Guggenheim Buy → Buy $86
2025-04-21 main Truist Securities Hold → Hold $65
2025-04-11 reit Guggenheim Buy → Buy $86
2025-03-17 reit HC Wainwright & Co. Buy → Buy $94
2025-03-14 init Jefferies — → Buy $80
2025-03-12 init JP Morgan — → Overweight $85
2025-03-05 main Guggenheim Buy → Buy $86
2025-03-03 reit HC Wainwright & Co. Buy → Buy $94
2024-12-11 init Leerink Partners — → Outperform $80
2024-11-11 reit HC Wainwright & Co. Buy → Buy $94
News
RSS: Latest ANIP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-13 COOK MEREDITH General Counsel — 500 $78.16 $39,080
2026-05-13 WALSH PATRICK D Director — 13,973 $80.63 $1,127,120
2026-05-12 ROWLAND THOMAS ANDREW Officer — 459 $79.21 $36,357
2026-05-12 GUTWERG ORI Officer — 2,772 $79.50 $220,374
2026-05-11 LALWANI NIKHIL SURESH Chief Executive Officer — 55,000 $77.57 $4,266,350
2026-04-13 COOK MEREDITH General Counsel — 500 $77.95 $38,975
2026-03-13 COOK MEREDITH General Counsel — 500 $72.62 $36,310
2026-03-13 MUTZ CHRISTOPHER Officer — 3,162 $71.64 $226,526
2026-03-11 ROWLAND THOMAS ANDREW Officer — 4,772 $74.91 $357,471
2026-03-09 DAVIS KRISTA Officer — 6,572 $74.13 $488,474
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
883.37
+43.78%
614.38
+26.20%
486.82
+53.87%
316.38
Operating Revenue
883.37
+43.78%
614.38
+26.20%
486.82
+53.87%
316.38
Cost Of Revenue
341.31
+36.41%
250.21
+37.85%
181.51
+30.79%
138.78
Reconciled Cost Of Revenue
341.31
+36.41%
250.21
+37.85%
181.51
+33.36%
136.10
Gross Profit
542.06
+48.85%
364.17
+19.28%
305.30
+71.90%
177.60
Operating Expense
460.83
+27.32%
361.95
+41.51%
255.77
+25.79%
203.33
Research And Development
51.66
+15.89%
44.58
+30.03%
34.29
+53.62%
22.32
Selling General And Administration
317.75
+27.28%
249.64
+54.39%
161.70
+30.35%
124.04
Other Operating Expenses
—
—
—
—
Total Expenses
802.14
+31.03%
612.16
+39.99%
437.29
+27.82%
342.12
Operating Income
81.23
+3562.31%
2.22
-95.52%
49.53
+292.47%
-25.73
Total Operating Income As Reported
111.09
+18922.77%
0.58
-98.76%
46.97
+233.13%
-35.28
EBITDA
207.27
+228.37%
63.12
-40.79%
106.60
+325.73%
25.04
Normalized EBITDA
174.58
+164.85%
65.92
-39.62%
109.16
+215.59%
34.59
Reconciled Depreciation
91.42
+34.97%
67.73
+13.28%
59.79
+0.23%
59.65
EBIT
115.85
+2613.04%
-4.61
-109.85%
46.81
+235.24%
-34.61
Total Unusual Items
32.69
+1269.48%
-2.79
-9.27%
-2.56
+73.21%
-9.55
Total Unusual Items Excluding Goodwill
32.69
+1269.48%
-2.79
-9.27%
-2.56
+73.21%
-9.55
Special Income Charges
29.86
+428.09%
-9.10
-255.82%
-2.56
+73.21%
-9.55
Other Special Charges
—
7.47
—
—
Impairment Of Capital Assets
0.77
-89.91%
7.60
0.00
-100.00%
0.11
Restructuring And Mergern Acquisition
-31.01
-4910.02%
-0.62
-124.20%
2.56
-72.89%
9.44
Net Income
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Pretax Income
95.79
+531.26%
-22.21
-211.78%
19.87
+131.71%
-62.66
Net Non Operating Interest Income Expense
-20.06
-13.96%
-17.60
+34.66%
-26.94
+3.96%
-28.05
Interest Expense Non Operating
20.06
+13.96%
17.60
-34.66%
26.94
-3.96%
28.05
Net Interest Income
-20.06
-13.96%
-17.60
+34.66%
-26.94
+3.96%
-28.05
Interest Expense
20.06
+13.96%
17.60
-34.66%
26.94
-3.96%
28.05
Other Income Expense
34.62
+607.04%
-6.83
-151.31%
-2.72
+69.40%
-8.88
Other Non Operating Income Expenses
1.93
+147.95%
-4.03
-2436.48%
-0.16
-123.73%
0.67
Gain On Sale Of Security
2.82
-55.22%
6.31
—
—
Tax Provision
17.45
+573.01%
-3.69
-437.60%
1.09
+107.40%
-14.77
Tax Rate For Calcs
0.00
+9.64%
0.00
+201.82%
0.00
-76.69%
0.00
Tax Effect Of Unusual Items
5.95
+1382.20%
-0.46
-229.78%
-0.14
+93.76%
-2.25
Net Income Including Noncontrolling Interests
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Net Income From Continuing Operation Net Minority Interest
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Net Income From Continuing And Discontinued Operation
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Net Income Continuous Operations
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Normalized Income
51.60
+418.69%
-16.19
-176.39%
21.20
+152.21%
-40.60
Net Income Common Stockholders
70.22
+448.52%
-20.15
-230.19%
15.47
+131.25%
-49.52
Otherunder Preferred Stock Dividend
6.96
0.00
-100.00%
1.68
—
Diluted EPS
3.32
+419.23%
-1.04
-222.35%
0.85
+127.87%
-3.05
Basic EPS
3.50
+436.54%
-1.04
-220.93%
0.86
+128.20%
-3.05
Basic Average Shares
20.05
+3.80%
19.32
+7.32%
18.00
+10.71%
16.26
Diluted Average Shares
21.23
+9.89%
19.32
+6.18%
18.19
+11.89%
16.26
Diluted NI Availto Com Stockholders
70.57
+450.27%
-20.15
-230.06%
15.49
+131.28%
-49.52
Average Dilution Earnings
0.35
0.00
-100.00%
0.02
—
Depreciation Amortization Depletion Income Statement
91.42
+34.97%
67.73
+13.28%
59.79
+4.95%
56.97
Depreciation And Amortization In Income Statement
91.42
+34.97%
67.73
+13.28%
59.79
+4.95%
56.97
Gain On Sale Of PPE
-0.38
-107.14%
5.35
0.00
0.00
Preferred Stock Dividends
1.16
-28.80%
1.62
+0.00%
1.62
+0.00%
1.62
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,440.38
+12.14%
1,284.47
+42.02%
904.42
+18.99%
760.09
Current Assets
753.12
+42.51%
528.46
+1.66%
519.82
+50.99%
344.26
Cash Cash Equivalents And Short Term Investments
294.72
+94.96%
151.17
-31.64%
221.12
+358.49%
48.23
Cash And Cash Equivalents
285.58
+97.14%
144.86
-34.49%
221.12
+358.49%
48.23
Other Short Term Investments
9.13
+44.78%
6.31
0.00
—
Receivables
281.08
+26.77%
221.73
+36.80%
162.08
-2.03%
165.44
Accounts Receivable
281.08
+26.77%
221.73
+36.80%
162.08
-2.03%
165.44
Gross Accounts Receivable
452.88
+29.56%
349.55
+34.78%
259.34
-20.57%
326.49
Allowance For Doubtful Accounts Receivable
-171.80
-34.41%
-127.82
-31.42%
-97.26
+39.61%
-161.05
Inventory
143.07
+4.59%
136.78
+23.01%
111.20
+5.54%
105.36
Raw Materials
74.36
+10.70%
67.17
+7.93%
62.24
-8.10%
67.73
Work In Process
2.97
+78.56%
1.67
-47.04%
3.14
+66.44%
1.89
Finished Goods
55.99
-3.41%
57.97
+60.14%
36.20
+29.19%
28.02
Prepaid Assets
11.03
+1328.37%
0.77
0.00
-100.00%
3.83
Restricted Cash
0.04
+9.09%
0.03
0.00
-100.00%
5.01
Assets Held For Sale Current
—
0.00
-100.00%
8.02
+0.00%
8.02
Other Current Assets
23.19
+29.01%
17.98
+3.30%
17.40
+107.46%
8.39
Total Non Current Assets
687.26
-9.09%
756.01
+96.57%
384.61
-7.51%
415.83
Net PPE
62.48
+9.87%
56.86
+27.52%
44.59
+3.11%
43.25
Gross PPE
115.17
+13.19%
101.74
+31.23%
77.53
+2.07%
75.96
Accumulated Depreciation
-52.69
-17.40%
-44.88
-36.27%
-32.94
-0.68%
-32.71
Properties
0.00
0.00
0.00
0.00
Land And Improvements
2.41
+52.34%
1.58
+2.13%
1.55
+0.00%
1.55
Buildings And Improvements
25.83
+5.71%
24.44
+36.72%
17.88
+7.30%
16.66
Machinery Furniture Equipment
76.04
+10.69%
68.70
+36.27%
50.41
-5.14%
53.15
Construction In Progress
8.82
+93.19%
4.57
-40.61%
7.69
+67.07%
4.60
Other Properties
0.65
-44.01%
1.16
—
—
Leases
1.41
+8.33%
1.30
0.00
—
Goodwill And Other Intangible Assets
542.01
-9.94%
601.82
+153.69%
237.23
-15.23%
279.86
Goodwill
62.48
+4.15%
59.99
+112.57%
28.22
+0.00%
28.22
Other Intangible Assets
479.53
-11.50%
541.83
+159.24%
209.01
-16.94%
251.63
Non Current Deferred Assets
69.07
-18.84%
85.11
-6.18%
90.71
+11.49%
81.36
Non Current Deferred Taxes Assets
69.07
-18.84%
85.11
-6.18%
90.71
+11.49%
81.36
Other Non Current Assets
—
—
—
11.36
Total Liabilities Net Minority Interest
899.65
+5.11%
855.94
+91.56%
446.82
+6.00%
421.55
Current Liabilities
278.11
+43.02%
194.45
+33.67%
145.48
+46.30%
99.44
Payables And Accrued Expenses
173.28
+60.07%
108.25
+37.21%
78.90
+43.77%
54.88
Payables
64.82
+21.90%
53.18
+18.57%
44.85
+53.04%
29.30
Accounts Payable
62.58
+37.08%
45.66
+24.46%
36.68
+25.18%
29.30
Current Accrued Expenses
108.45
+96.92%
55.08
+61.75%
34.05
+33.15%
25.57
Pensionand Other Post Retirement Benefit Plans Current
37.90
+0.46%
37.73
+58.60%
23.79
+130.66%
10.31
Total Tax Payable
2.24
-70.23%
7.52
-7.88%
8.16
0.00
Income Tax Payable
2.24
-70.23%
7.52
-7.88%
8.16
0.00
Current Debt And Capital Lease Obligation
17.27
+88.27%
9.17
+979.06%
0.85
+0.00%
0.85
Current Debt
17.27
+88.27%
9.17
+979.06%
0.85
+0.00%
0.85
Other Current Borrowings
17.27
+88.27%
9.17
+979.06%
0.85
+0.00%
0.85
Current Deferred Liabilities
—
—
—
—
Current Deferred Revenue
—
—
—
—
Other Current Liabilities
0.17
+475.86%
0.03
-99.76%
12.27
—
Total Non Current Liabilities Net Minority Interest
621.54
-6.04%
661.49
+119.51%
301.35
-6.45%
322.11
Long Term Debt And Capital Lease Obligation
599.77
-2.46%
614.92
+115.90%
284.82
-0.30%
285.67
Long Term Debt
599.77
-2.46%
614.92
+115.90%
284.82
-0.30%
285.67
Other Non Current Liabilities
21.77
-14.97%
25.61
+54.93%
16.53
-54.64%
36.44
Stockholders Equity
540.72
+26.18%
428.53
-6.35%
457.60
+35.17%
338.54
Common Stock Equity
540.72
+33.95%
403.68
-6.72%
432.75
+37.95%
313.69
Capital Stock
0.00
-99.99%
24.85
+0.00%
24.85
+0.00%
24.85
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
-100.00%
24.85
+0.00%
24.85
+0.00%
24.85
Share Issued
23.11
+7.31%
21.54
+3.89%
20.73
+17.50%
17.64
Ordinary Shares Number
22.49
+6.55%
21.11
+3.13%
20.47
+16.99%
17.49
Treasury Shares Number
0.62
+44.64%
0.43
+62.75%
0.26
+77.11%
0.15
Additional Paid In Capital
596.04
+14.70%
519.65
+1.08%
514.10
+27.28%
403.90
Retained Earnings
-23.10
+76.97%
-100.28
-25.14%
-80.13
+17.63%
-97.29
Gains Losses Not Affecting Retained Earnings
1.03
-80.67%
5.34
-39.66%
8.86
-27.21%
12.17
Treasury Stock
33.25
+58.03%
21.04
+108.71%
10.08
+97.90%
5.09
Other Equity Adjustments
1.03
-80.67%
5.34
-39.66%
8.86
-27.21%
12.17
Total Equity Gross Minority Interest
540.72
+26.18%
428.53
-6.35%
457.60
+35.17%
338.54
Total Capitalization
1,140.49
+9.30%
1,043.45
+40.55%
742.42
+18.94%
624.21
Working Capital
475.00
+42.22%
334.00
-10.77%
374.34
+52.90%
244.82
Invested Capital
1,157.76
+12.65%
1,027.77
+43.06%
718.42
+19.69%
600.21
Total Debt
617.03
-1.13%
624.09
+118.47%
285.67
-0.30%
286.52
Net Debt
331.45
-30.84%
479.23
+642.44%
64.55
-72.91%
238.29
Net Tangible Assets
-1.28
+99.26%
-173.29
-178.64%
220.37
+275.52%
58.68
Tangible Book Value
-1.28
+99.35%
-198.14
-201.34%
195.52
+477.88%
33.83
Current Provisions
49.50
+26.05%
39.27
+32.33%
29.68
-11.14%
33.40
Derivative Product Liabilities
—
—
—
—
Financial Assets
13.71
+12.16%
12.22
+1.23%
12.07
+6.26%
11.36
Inventories Adjustments Allowances
—
—
—
-10.28
Non Current Accrued Expenses
0.00
-100.00%
20.96
0.00
—
Other Inventories
9.74
-2.35%
9.98
+3.74%
9.62
+24.57%
7.72
Preferred Shares Number
—
0.03
+0.00%
0.03
+0.00%
0.03
Preferred Stock Equity
—
24.85
+0.00%
24.85
+0.00%
24.85
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
185.22
+189.34%
64.02
-46.19%
118.96
+481.24%
-31.20
Cash Flow From Continuing Operating Activities
185.22
+189.34%
64.02
-46.19%
118.96
+481.24%
-31.20
Net Income From Continuing Operations
78.34
+522.94%
-18.52
-198.63%
18.78
+139.21%
-47.90
Depreciation Amortization Depletion
91.42
+34.97%
67.73
+13.28%
59.79
+0.23%
59.65
Depreciation And Amortization
91.42
+34.97%
67.73
+13.28%
59.79
+0.23%
59.65
Other Non Cash Items
-27.90
-284.16%
15.15
+128.93%
6.62
-27.84%
9.17
Stock Based Compensation
37.93
+29.26%
29.34
+42.09%
20.65
+41.46%
14.60
Asset Impairment Charge
0.77
-89.91%
7.60
0.00
-100.00%
0.57
Deferred Tax
14.24
+164.97%
-21.91
-86.65%
-11.74
+23.03%
-15.25
Deferred Income Tax
14.24
+164.97%
-21.91
-86.65%
-11.74
+23.03%
-15.25
Operating Gains Losses
0.38
-81.99%
2.12
—
-0.75
Unrealized Gain Loss On Investment Securities
-2.82
+55.22%
-6.31
0.00
0.00
Gain Loss On Sale Of PPE
—
-5.35
0.00
+100.00%
-0.75
Change In Working Capital
-7.12
+36.32%
-11.19
-144.99%
24.86
+148.46%
-51.30
Change In Receivables
-58.53
-177.56%
-21.09
-727.78%
3.36
+109.10%
-36.91
Changes In Account Receivables
-58.53
-177.56%
-21.09
-727.78%
3.36
+109.10%
-36.91
Change In Inventory
-5.96
+72.00%
-21.29
-264.44%
-5.84
+75.28%
-23.63
Change In Prepaid Assets
-5.02
-335.98%
2.13
+123.62%
-9.02
-1029.70%
-0.80
Change In Payables And Accrued Expense
67.69
+216.73%
21.37
-23.91%
28.09
+125.88%
12.44
Change In Accrued Expense
52.54
+151.45%
20.89
+1.74%
20.54
+171.75%
7.56
Change In Payable
15.16
+3064.09%
0.48
-93.66%
7.55
+54.82%
4.88
Change In Account Payable
15.16
+3064.09%
0.48
-93.66%
7.55
+49.90%
5.04
Change In Other Working Capital
-5.30
-168.97%
7.69
-7.04%
8.27
+444.69%
-2.40
Investing Cash Flow
-34.32
+91.52%
-404.72
-2086.37%
-18.51
-17.62%
-15.74
Cash Flow From Continuing Investing Activities
-34.32
+91.52%
-404.72
-2086.37%
-18.51
-17.62%
-15.74
Net PPE Purchase And Sale
-13.84
-408.27%
-2.72
+69.31%
-8.87
-9.13%
-8.13
Purchase Of PPE
-13.84
+14.79%
-16.24
-83.09%
-8.87
+0.09%
-8.88
Sale Of PPE
0.00
-100.00%
13.51
0.00
-100.00%
0.75
Capital Expenditure
-34.32
-102.45%
-16.95
+8.42%
-18.51
-12.49%
-16.45
Net Business Purchase And Sale
0.00
+100.00%
-401.28
0.00
+100.00%
-0.03
Purchase Of Business
0.00
+100.00%
-401.28
0.00
+100.00%
-0.03
Net Intangibles Purchase And Sale
-20.49
-2757.18%
-0.72
+92.56%
-9.64
-27.23%
-7.58
Purchase Of Intangibles
-20.49
-2757.18%
-0.72
+92.56%
-9.64
-27.23%
-7.58
Financing Cash Flow
-9.94
-103.75%
264.94
+292.87%
67.44
+1415.63%
-5.13
Cash Flow From Continuing Financing Activities
-9.94
-103.75%
264.94
+292.87%
67.44
+1415.63%
-5.13
Net Issuance Payments Of Debt
-10.16
-102.94%
345.22
+11607.30%
-3.00
+0.00%
-3.00
Issuance Of Debt
0.00
-100.00%
641.25
0.00
0.00
Repayment Of Debt
-10.16
+96.57%
-296.03
-9767.70%
-3.00
+0.00%
-3.00
Long Term Debt Issuance
0.00
-100.00%
641.25
0.00
0.00
Long Term Debt Payments
-10.16
+96.57%
-296.03
-9767.70%
-3.00
+0.00%
-3.00
Net Long Term Debt Issuance
-10.16
-102.94%
345.22
+11607.30%
-3.00
+0.00%
-3.00
Short Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
-12.21
-11.41%
-10.96
-114.50%
75.57
+3957.48%
-1.96
Common Stock Payments
-12.21
-11.41%
-10.96
-119.75%
-4.99
-154.57%
-1.96
Cash Dividends Paid
-1.16
+28.80%
-1.62
+0.00%
-1.62
+0.00%
-1.62
Repurchase Of Capital Stock
-12.21
-11.41%
-10.96
-119.75%
-4.99
-154.57%
-1.96
Proceeds From Stock Option Exercised
13.60
+109.68%
6.49
-27.88%
9.00
+517.01%
1.46
Net Other Financing Charges
-0.03
+99.96%
-74.18
-493.42%
-12.50
—
Changes In Cash
140.96
+286.07%
-75.76
-145.12%
167.89
+422.44%
-52.07
Effect Of Exchange Rate Changes
-0.23
+50.43%
-0.47
0.00
0.00
Beginning Cash Position
144.89
-34.47%
221.12
+315.38%
53.23
-49.45%
105.30
End Cash Position
285.62
+97.12%
144.89
-34.47%
221.12
+315.38%
53.23
Free Cash Flow
150.90
+220.64%
47.06
-53.15%
100.45
+310.77%
-47.66
Interest Paid Supplemental Data
26.93
+10.46%
24.38
-22.44%
31.43
+46.35%
21.48
Income Tax Paid Supplemental Data
17.67
-7.28%
19.06
+1452.20%
1.23
+326.39%
0.29
Change In Income Tax Payable
—
-1.42
-111.80%
11.99
+7594.37%
-0.16
Change In Tax Payable
—
-1.42
-111.80%
11.99
+7594.37%
-0.16
Common Stock Issuance
0.00
0.00
-100.00%
80.56
0.00
Issuance Of Capital Stock
0.00
0.00
-100.00%
80.56
0.00
Net Preferred Stock Issuance
—
—
0.00
0.00
Preferred Stock Dividend Paid
-1.16
+28.80%
-1.62
+0.00%
-1.62
+0.00%
-1.62
Preferred Stock Issuance
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category